Fallopian Tube Cancer
📧 Sign up to get email alerts when something new happens for Fallopian Tube Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2012-08-24Clinical Trial Update: S0009 Combination Chemo and Surgery in Stage III or Stage IV Ovarian Cancer [Phase 2]
Phase 2 SWOG trial evaluating the combination of chemotherapy and surgery for stage III or IV ovarian cancer; results were posted after comp…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PS-341 Plus Carboplatin in Platinum and Taxane Resistant Recurrent Ovarian Cancer, Primary Peritoneal Cancer, and Fallopian Tube Cancer [Phase 1]
Phase 1 trial evaluating PS-341 (bortezomib) in combination with carboplatin for platinum- and taxane-resistant recurrent ovarian cancer, pr…
-
CLINICAL_TRIALS trial_result · 2012-08-02Clinical Trial Update: PEG-Interferon Alfa-2b in Treating Patients With Platinum-Resistant Ovarian Epithelial, Peritoneal, or Fallopian Tube Cancer [Phase 1, Phase 2]
A terminated Phase 1/2 trial evaluating PEG-interferon alfa-2b in platinum-resistant ovarian, fallopian tube, and peritoneal cancer.
-
CLINICAL_TRIALS trial_result · 2012-06-26Clinical Trial Update: Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer [Phase 2]
This Phase 2 trial evaluated vandetanib for ovarian, fallopian tube, and primary peritoneal cancers; the study was terminated and results we…
-
CLINICAL_TRIALS trial_result · 2012-06-06Clinical Trial Update: Outcomes in Ovarian Cancer and Fallopian Tube Cancer Patients Using Complementary Alternative Medicine [NA]
A completed clinical trial investigating complementary and alternative medicine approaches in ovarian, peritoneal primary, and fallopian tub…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2012-05-31Clinical Trial Update: Liposomal Doxorubicin and Carboplatin in Treating Patients With Gynecologic Cancer [Phase 1, Phase 2]
This trial update reports the completion of a Phase 1/2 study evaluating liposomal doxorubicin with carboplatin in gynecologic cancers, incl…
-
CLINICAL_TRIALS trial_result · 2012-05-16Clinical Trial Update: Chemotherapy in Treating Patients With Recurrent, Metastatic, or Unresectable Ovarian, Fallopian Tube, or Peritoneal Cancer [Phase 2]
Phase 2 chemotherapy trial for recurrent, metastatic, or unresectable ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-04-16Clinical Trial Update: EPO906 Therapy in Patients With Advanced Ovarian, Primary Fallopian, or Primary Peritoneal Cancer [Phase 2]
Phase 2 clinical trial update on EPO906 therapy for advanced ovarian, fallopian tube, or primary peritoneal cancer has completed.
-
CLINICAL_TRIALS trial_result · 2012-02-15Clinical Trial Update: Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based Chemotherapy [Phase 2]
A Phase 2 study evaluating MORAb-003 (farletuzumab) for women with ovarian cancer that relapsed after platinum-based chemotherapy has comple…
-
CLINICAL_TRIALS trial_result · 2011-11-03Clinical Trial Update: A Study of Carboplatin and Gemcitabine Plus Bevacizumab in Patients With Ovary, Peritoneal, or Fallopian Tube Carcinoma [Phase 3]
A Phase 3 trial of carboplatin and gemcitabine plus bevacizumab in ovarian, fallopian tube, or primary peritoneal cancer has completed and p…
-
CLINICAL_TRIALS trial_result · 2011-10-12Clinical Trial Update: Abraxane Plus Carboplatin for Recurrent Platinum-Sensitive Ovarian Cancer [Phase 2]
A phase 2 study evaluating Abraxane (nab-paclitaxel) in combination with carboplatin for recurrent platinum-sensitive ovarian cancer has com…
-
CLINICAL_TRIALS trial_result · 2011-06-03Clinical Trial Update: Retrospective Case Study to Validate Existing Chemoresponse Marker Test in Ovarian, Peritoneal or Fallopian Cancer Cases
A completed retrospective study to validate a chemoresponse marker test for ovarian, peritoneal, and fallopian tube cancers.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Phase II Clinical Study of Pegylated Liposomal Doxorubicin Hydrochloride Injection as 2nd-line or Later Therapy in Patients With Mullerian Carcinoma (Epithelial Ovarian Carcinoma, Primary Carcinoma of Fallopian Tube, Peritoneal Carcinoma) Having Prior Platinum-Based Chemotherapy [Phase 2]
Phase II trial of pegylated liposomal doxorubicin as second-line or later therapy for Mullerian carcinomas, including epithelial ovarian can…
-
CLINICAL_TRIALS trial_result · 2011-04-26Clinical Trial Update: Bortezomib and Carboplatin in Treating Patients With Recurrent or Progressive Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
A Phase 1 study evaluating safety and preliminary efficacy of the combination of bortezomib and carboplatin in patients with recurrent or pr…
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: Ph II Atrasentan + DOXIL in Recurrent Ovarian/Fallopian/Peritoneal Serous Papillary Adenocarcinoma [Phase 2]
Phase II trial evaluating atrasentan in combination with DOXIL for recurrent ovarian, fallopian tube, and peritoneal cancer was terminated; …
-
CLINICAL_TRIALS trial_result · 2011-04-20Clinical Trial Update: Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum [Phase 2]
Phase 2 clinical trial evaluating weekly paclitaxel in women with Stage III/IV ovarian cancer refractory to paclitaxel and platinum therapy.
-
CLINICAL_TRIALS trial_result · 2011-04-05Clinical Trial Update: Oxaliplatin and Topotecan in Treating Patients With Previously Treated Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer [Phase 1]
This clinical trial update reports the completion of a Phase 1 study evaluating oxaliplatin and topotecan in patients with previously treate…
-
CLINICAL_TRIALS trial_result · 2011-02-25Clinical Trial Update: Taxol® in Monotherapy or in Combination With Topotecan or Carboplatin in Patients With Epithelial Ovarian Cancer in Early Relapse [Phase 2]
Phase 2 trial of Taxol (paclitaxel) as monotherapy or in combination with topotecan or carboplatin for epithelial ovarian cancer in early re…
-
CLINICAL_TRIALS trial_result · 2011-01-10Clinical Trial Update: Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer [Phase 2]
This document reports the Phase 2 results of a chemoimmunotherapy study in epithelial ovarian cancer. The trial status is completed and resu…
-
CLINICAL_TRIALS trial_result · 2011-01-04Clinical Trial Update: A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer [Phase 2]
Phase II open-label trial evaluating GW786034 in ovarian cancer and peritoneal cancer; study completed with results posted in 2011.
-
CLINICAL_TRIALS trial_result · 2010-12-22Clinical Trial Update: Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer [Phase 3]
Phase 3 trial evaluated pyridoxine (vitamin B6) in preventing hand-foot syndrome in patients treated with liposomal doxorubicin for several …
-
CLINICAL_TRIALS trial_result · 2010-11-16Clinical Trial Update: Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal Cancer [Phase 2]
Phase 2 trial of bevacizumab with carboplatin and paclitaxel in ovarian, fallopian tube, or primary peritoneal cancer; the study was termina…
-
CLINICAL_TRIALS trial_result · 2010-10-19Clinical Trial Update: Letrozole in Patients With Ovarian Tumors [Phase 2]
Phase 2 trial of letrozole in patients with ovarian tumors (ovarian, fallopian tube, and peritoneal cancer) was terminated with results post…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Erlotinib, Docetaxel, and Carboplatin in Treating Patients With Newly Diagnosed Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer [Phase 1, Phase 2]
A Phase 1/2 trial evaluated the three-drug combination of erlotinib, docetaxel, and carboplatin in newly diagnosed Stage III or Stage IV ova…
-
CLINICAL_TRIALS trial_result · 2010-09-21Clinical Trial Update: Gemcitabine and Topotecan in Treating Patients With Recurrent or Persistent Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer [Phase 2]
Phase 2 trial of gemcitabine and topotecan in recurrent or persistent ovarian, fallopian tube, or primary peritoneal cancer has completed.